ethyl N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)carbamate

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 恶嗪烷类
• 英文名称: ethyl N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)carbamate
• 化学式: C9H15N4O4+
• 分子量: 243.24
• InChiKey: XLFWDASMENKTKL-UHFFFAOYSA-O

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  17
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  80.7
• 氢给体数：
  1
• 氢受体数：
  6

文献信息

• MEDICAL IMPLANT HAVING A COATING COMPOSED OF OR CONTAINING AT LEAST ONE ACTIVE SUBSTANCE
  申请人：Gratz Matthias

  公开号：US20110244016A1

  公开（公告）日：2011-10-06

  One embodiment of the invention relates to a medical implant whose surface is completely or partially covered by a coating composed of at least one active substance or containing at least one active substance.
• US7803559B1
  申请人：——

  公开号：US7803559B1

  公开（公告）日：2010-09-28
• [EN] PREVENTION OF ANESTHETIC-INDUCED NEUROCOGNITIVE DYSFUNCTION<br/>[FR] PRÉVENTION D'UN DYSFONCTIONNEMENT NEUROCOGNITIF INDUIT PAR UN ANESTHÉSIQUE
  申请人：UNIV JOHNS HOPKINS

  公开号：WO2020150698A1

  公开（公告）日：2020-07-23

  Methods for treating or preventing a cognitive impairment in a subject in need of treatment thereof, the method comprising administering to the subject a therapeutically effective amount of an agent that enhances the NO-cGMP-PKG pathway are disclosed.